This website uses cookies to enhance the user experience.
||
A

AS LALU946 490 016

Purchase and sale
Limited company
Søndre Sprovei 38 1454 FAGERSTRAND, Norge
Goods and trade
/ Purchase and sale
/ 46.460 Wholesale of pharmaceutical goods

AS LALU

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO
ØL

Øivind Larsen-Lund1954

Chairman of the board
ØL

Øivind Larsen-Lund1954

Years since formation
30 years
since Feb 19, 1995
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
80
1 share class
Total number of shareholders
1
person
Belongs to group of

Financials

Total operating income 2024
179,969
NOK
Annual total result 2024
832,780
NOK
Total equity 2024
30,168,110
NOK
Last update: Sep 9, 2025

Management

Management / administration

NameRoleShares
ØL

Øivind Larsen-Lund

1954

Managing Director/CEO
100 %
directly

Board

NameRoleShares
ØL

Øivind Larsen-Lund

1954

Chairman
100 %
directly
MA

Mette Anita Bragmo

1956

Alternate Member-

Others

NameRoleShares
P
PEDERSEN & SKOGHOLT AS
Auditor-
Q
QUALITY ACCOUNTING AS
Accountant-

Top 10 individual shareholders

NameRoleShares
ØL

Øivind Larsen-Lund

1954

Managing Director/CEO, Chairman
100 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
ØL

Øivind Larsen-Lund

1954

Ordinary shares
80
100 %

Shares owned by the AS LALU

NameShare classTotal number of sharesShare
C
CANTEC AS
Ordinary shares
60
100 %
G
GRANMO AS
Ordinary shares
100
100 %
S
SALMON EVOLUTION ASA
NO0010892094
8,000
< 0.01 %
S
SALMAR ASA
NO0010310956
30
< 0.01 %
E
EQUINOR ASA
NO0010096985
210
< 0.01 %
Last update: Jun 2, 2025

Group structure

  • AS LALU
    Total operating income 2024: NOK 179,969
    Operating profit 2024: NOK -172,555
    Employees: 0

Financials

in NOK

Summary

Year2024202320222021
Total operating income
179,969
60,000
60,000
30,000
Annual Total Result
832,780
1,252,154
1,869,980
-175,348
Total assets
30,649,629
30,145,996
28,916,726
28,545,413
Total liabilities
481,519
10,666
33,550
32,218
Total equity
30,168,110
30,135,330
28,883,176
28,513,195

P&L

Year2024202320222021
Total operating income
179,969
60,000
60,000
30,000
Total operating costs
352,524
311,098
285,558
307,384
Operating result
-172,555
-251,098
-225,558
-277,384
Financial income/costs
1,238,374
1,459,377
2,058,014
52,302
Profit before tax
1,065,819
1,208,279
1,832,456
-225,082
Total tax & extraordinary income/cost
233,039
-43,875
-37,524
-49,734
Annual Total Result
832,780
1,252,154
1,869,980
-175,348

Balance overview

Year2024202320222021
Total fixed assets
24,055,311
23,856,575
23,700,304
23,692,987
Total current assets
6,594,319
6,289,421
5,216,421
4,852,426
Total assets
30,649,629
30,145,996
28,916,726
28,545,413
Short term debt
425,251
10,666
33,550
32,218
Long term debt
56,268
0
0
0
Total liabilities
481,519
10,666
33,550
32,218
Contributed capital
120,000
120,000
120,000
120,000
Retained earnings
30,048,110
30,015,330
28,763,176
28,393,195
Total equity
30,168,110
30,135,330
28,883,176
28,513,195
Total equity and liabilities
30,649,629
30,145,996
28,916,726
28,545,413

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods